Abstract: A topological substructural molecular design approach (TOPS-MODE) has been used to formulate structural rules for binding of substrates of P-glycoprotein (P-gp). We first review some of the models developed in the recent literature for predicting binding to Pgp. Then, we develop a model using TOPS-MODE, which is able to identify 88.4% of substrates and 84.2% of non-substrates. When the model is presented to an external prediction set of 100 substrates and 77 nonsubstrates it identifies correctly 81.8% of all cases. Using TOPS-MODE strategy we found structural contributions for binding to P-gp, which identifies 24 structural fragments responsible for such binding. We then carried out a chemico-biological analysis of some of the structural fragments found as contributing to P-gp binding of substrates. We show that in general the model developed so far can be used as a virtual screening method for identifying substrates of P-gp from large libraries of compounds.
INTRODUCTION
In QSAR analysis a quantitative model is used to predict the biological response of a chemical based on a series of molecular descriptors or physicochemical properties [1] . However, the structural information contained in such descriptors or properties is many times encrypted [2] in a way that does not allow the extraction of structural rules to form a knowledge base similar to those provided by human expertise [3] . In the case of toxicological assessment of chemicals these knowledge bases are the heart of expert systems, such as DEREK [4] and TOPKAT [5] , used to evaluate the toxicological profile of chemicals [6] .
An important step in the development of any toxicological or metabolic activity of a chemical is the transport to the organs where the final effect takes place. One of the most important proteins in the transport of various molecules across extra-and intra-cellular membranes is P-glycoprotein (P comes from permeability). Pglycoprotein (P-gp), is a 170-kDa glycoprotein, which is a member of the ATP binding cassette (ABC) super-family of transport proteins and couples hydrolysis of ATP to the transport of compounds out of the cell [7] [8] [9] [10] [11] . P-gp behaves quite differently from conventional transporters in two respects [12] : i.
it does not transport a specific substrate but a wide variety of chemically most diverse compounds, and ii. it seems to extract its substrates directly out of the membrane [13] . In MDR cell lines, drugs entering the cells through passive diffusion bind to P-gp and are actively pumped outward from the cells. There is some evidence that P-gp can also decrease the influx of cytotoxic drugs into the cell [14, 15] .
In conjunction with drug-metabolizing enzymes, P-gp provides a protective physiological barrier capable of altering the rate and extent of xenobiotic entry into the systemic circulation [16] .
REVIEW OF CONCEPTS AND MODELS 1.P-gp Efflux Substrates
P-gp is expressed in many normal tissues such as intestine, liver, kidney, lung, and endothelia of brain, testis, and placenta, consistent with its role as a natural detoxification system. Because of this activity it can have a high impact on many drugs' pharmacokinetics and pharmacodynamics [10, 17] . Particularly, P-gp has been shown to limit oral absorption, modulate hepatic, renal, or intestinal elimination, and restrict central nervous system entry of certain drugs [18] [19] [20] . In addition, because of its broad substrate specificity, P-gp mediated drug-drug interactions may occur when substrates and inhibitors are coadministered [21] . For example, Pgp inhibitors lead to an increase in the systemic exposure and tissue distribution of coadministered P-gp substrate drugs that could cause serious adverse effects [21, 22] .
In comparison to most of other transport proteins that recognize specific chemical substrates, P-glycoprotein is unusual since it transports structurally and mechanistically unrelated agents out of the cell [9] . It is evident from the literature that compounds that interact with the P-gp efflux pump represent a wide spectrum of chemical structures as well as different classes of drugs [23] . Overexpression of this protein may result in multidrug resistance (MDR) and it is a major cause of the failure of cancer chemotherapy, in addition to decreasing the efficacy of antibiotics and antiviral agents [24, 25] . Other therapeutic agents are also affected by P-gp, such as HIV-protease inhibitors, detergents, antibiotics, immunosuppressives, antihypertensives and many others [10, 26] . Some of these agents are listed in Table 1 . As can be seen these compounds are chemically diverse; some of them are positively charged at physiological pH and, since most of them are relatively hydrophobic, they permeate the cell membrane by passive diffusion.
Several in vitro screening assays such as the monolayer efflux, ATPase activity, and calcein-AM fluorescence assays have been suggested to classify compounds as P-gp substrates [24, 25, [27] [28] [29] . Each of these assays provides different information and has advantages and disadvantages [23] . However, the assays are not designed to distinguish P-gp substrates from inhibitors [30] [31] [32] and do not directly measure transport. The limitations of each assay makes selection difficult [27] . Nevertheless, methods that increase the identification of P-gp substrate are therefore useful during early drug development.
Prediction of P-gp substrate specificity (S P-gp ) can be viewed as a constituent part of a compound's pharmaceutical profiling in drug design. This task is difficult to achieve due to several factors that raised many contradictory opinions [33] :
i.
the disparity between the S P-gp values obtained in different assays; ii.
the confusion between P-gp substrate and inhibitors; iii.
the confusion between lipophilicity and amphiphilicity of Pgp substrate; iv.
the dilemma of describing class-specific relationships when P-gp has no binding sites of high ligand specificity.
Outcome and Mechanisms for P-gp Interaction
P-glycoprotein is encoded by the MDR1 gene in humans and the mdr1 (also called mdr1b) and mdr3 (also called mdr1a) genes in rodents [22, 34] . High levels of P-gp expression have been observed in the endothelial cells of the blood-brain barrier [9, 35, 36] , in certain cells of the adrenal gland, liver, pancreas, kidney proximal tubules, colon, jejunum [9, 37] , digestive tract [9, 38] , cells of the luminal surface of the secretory epithelium of the gravid uterus [9, 39] and placental trophoblast. This demonstrates its protective roles in limiting drug absorption, contributing to pharmacokinetics, and probably impacting pharmacodynamics and toxicity [20, 40, 41] . High expression levels of P-gp are also observed in many cancer cells [9, 42] .
The mechanism for P-glycoprotein modulation may be different for different classes of compounds [10, 23] . The three main mechanisms of modulators are:
i. direction interaction with one or more of the binding sites on P-gp thus blocking transport by acting as competitive or non-competitive inhibitors; ii.
inhibition of ATP binding, ATP hydrolysis or coupling of ATP hydrolysis to the translocation of the substrate; iii.
interaction with the lipid membrane of the cell thus perturbing the membrane environment or modifying the drugmembrane interaction. A better understanding of this interplay would help to understand not only the mechanism of action of P-gp, but also possible unexpected physiological roles. On the one hand, lipids can modulate P-gp catalytic activity as well as drug binding. Therefore the physiological role(s) of P-gp may be highly tissue-dependent, as plasma membrane lipid composition depends on cell type. On the other hand, a possible role for P-gp in lipid transport or metabolism would involve it with a variety of cellular processes (see Fig. 1 ) because increasing evidence shows that lipids have many different functions, such as signal transduction or modulation of peripheral or integral proteins [43, 44] .
In Silico Studies
In vitro assays and in silico models for predicting P-gp substrates or inhibitors have been recognized to be valuable tools during early phases of drug development [22] . Using different sets of molecules and various types of in vitro assays to measure P-gp activities, a number of structure-property relationships (SPR) have been developed to elucidate the physicochemical properties characterizing the P-gp substrates [9, 12, 23, 32, [45] [46] [47] . More detailed 3D pharmacophore hypotheses for P-gp substrates and inhibitors have also been proposed [48] [49] [50] [51] .
In one of these works, Wang et al. [52] recently published a model based on an unsupervised machine learning approach for classifying potential P-gp substrates and inhibitors. It must be recognized that there are several difficulties in developing computational models due to broad substrate specificity, multiple binding Pgp sites and different modulator mechanisms (i.e. competitive, noncompetitive, alteration of cell membrane lipids, etc.) [10] . However, the availability of virtual screening tools for discriminating substrates and nonsubstrates, as well as inhibitors would be helpful in the design of new drugs. In particular, these models can be used for assessing the potential for drug-enzyme interactions of new candidates.
A data set of 609 diverse compounds tested for MDR reversing (MDRR) activity against P388/ADR-resistant cell lines was submitted to the MULTICASE computer program for structure-activity analysis in order to design more effective MDRR agents [15] . In such a way some substructural features related to MDRR activity were identified. Based on quantitative structure-activity relationship study of MDRR agents (modulators, chemosensitizers, reverters), some compounds with desired substructural features and activity were identified from the MACCS-II and National Cancer Institute DIS databases and tested experimentally.
On the other hand, Bakken and Jurs [53] develop classification models for MDRR activity based on structural descriptors. The same set of compounds employed by Klopman et. al. [15] is used this study. Structure-based descriptors are used to develop classification models using linear discriminant analysis (LDA). Predictive ability of all models developed is examined using external prediction sets. Models developed could be used to screen large libraries of compounds aiming the identification of those likely to display activity as MDRR agents. These models, validated using external data sets, can be implemented for virtual screenings in early phases of drug discovery. This work set the basis of our present study. Fig. (1) . Possible physiological role for P-glycoprotein beyond its protective functions toward xenobiotics.
Necessity for Automated Rule-Extraction
Classical QSARs permits the classification of chemicals as substrates/non-substrates, but their information cannot be easily incorporated on the existing expert systems due to the cryptic nature of the variables included in such models [2] . On the other hand, the traditional methods for extracting knowledge from human expertise requires a great amount of information about a set of chemicals permitting the experts their generalization. In addition, the rate of producing new chemical entities overtakes the rate of their toxicological profile evaluation. Thus a method that permits to extract knowledge from the minimum information available about a series of chemicals is necessary to keep expert systems updated. In this sense, an expert system can be considered as knowledge archive where a collection of knowledge is expressed using some formal representation language. An automatic knowledge generator is a methodology that will provide new structural alerts to the knowledge archive in a cyclic way keeping it updated. In previous works [54] [55] [56] we have shown that the so-called topological sub-structural molecular design (TOPS-MODE) approach [57] [58] [59] [60] [61] [62] represents a useful platform for the automatic generation of toxicological structural alerts. In these works a general strategy for knowledge flow concerning skin sensitization and chromosome aberrations based on the combined use of TOPS-MODE and DEREK expert system was proposed [54] [55] [56] .
Taking into consideration the above mentioned, this study describes a quantitative structure-activity relationship (QSAR) analysis on a dataset of compounds assayed for P-gp activity. Then, the main purpose of the current work is to generate structural alert rules that permit the identification of substrates of P-gp in chemicals database using information coded in their molecular structure. Thus we develop a classification model using the TOPS-MODE approach, which allows the calculation of the contribution of each part of a molecule to the activity under study. Using this information we identify structural regions responsible for the P-gp activity of chemicals and transform this information into structural alert rules which are ready to be implemented in expert systems such as DEREK.
DATA SET
All experimental procedures were carried out by Ramu and Ramu, and experimental details can be found in the literature [63] [64] [65] . Briefly, ED 50 values were collected for a line of P388 murine leukemia cells that were resistant to adriamycin, ADR (ED 50 values denote the drug concentration effective in inhibiting cell growth by 50%). The ED 50 values were collected for cells in the presence of the drug and for cells in the presence of the drug and 200 nM ADR. The drug's ability to reverse MDR (R-Fold, RF) was measured as: RF = (ED 50 with no ADR) / (ED 50 with 200 nM ADR). An RF value of 1.0 indicates no ability to reverse MDR (non-substrate), while large RF values indicate excellent ability to reverse MDR (substrate). The compound structures and their associated RF values were taken from the literature [53] . Compounds were classified as P-gp substrate if there were reported to be bound and transported out of the cell by P-gp, and compounds were designed P-gp nonsubstrates if they were not bound neither transported by P-gp.
A data set of compounds was carefully assembled from literature [15, 53] . We left out 12 of the 609 compounds available due to software limitations (because isomer relations), leaving 597 compounds for analysis [53] . Compounds reported as moderate by Bakken-Jurs [53] , 75 in total, were also removed by taking into account the following considerations:
we are looking for a discrimination "exclusively" between actives substrates and non-substrates, so we discard compounds having a moderate activity (marginal compounds according to Klopman et. al. [15] ). Nevertheless, we keep in mind the same discrimination considered by Bakken & Jurs, taken as the first analysis approach in their work (see Table  6 in [53] ); ii.
the substrate (moderates and actives) composition is 62.7 % and only 37.3 % for non-substrates [15, 53] . This could falsify the QSAR results. In the present work we based our study in one of two classifications given by both precedent works [15, 53] , specifically the one referred to data set 1 (see Table 1 in [53] ), which will be described later on in this paper; iii.
in fact the "moderates (marginal) compounds" are classified as active or inactives substrates by some authors [9. 25, 47, 49, 66] , which gives an idea of the "marginality" of them, not showing a clear cut-off criterion for the classification of these compounds (actives, moderates, inactives). Some of these chemicals are shown in Table 1 . Consequently, our data is formed by 522 compounds, from which 299 are substrates and 223 are non-substrates (57.3 % and 42.7 % respectively).
In order to generate classification models, compounds were first grouped according to MDRR activity. Bakken-Jurs [53] suggests labeling compounds with RF 2.0 as inactive and compounds with RF > 4.2 as active. Such a division was used in the present study and will be referred to as data set 1 (see Table 1 in [53] ). The division of compounds into classes based on activity is somewhat arbitrary [53] . Therefore, classification models were generated for the two-class problem (inactive/active).
This data set was subdivided according to [53] into two subsets one containing 345 compounds (199 actives and 146 inactives) used as a training set for developing the classification model. The other subset formed by 177 compounds (100 actives and 77 inactives) was used as a prediction set.
METHODOLOGY 3.1. The TOPS-MODE Approach
In the last 12 years we have developed an approach to QSAR/QSPR and molecular design. It is known as TOPS-MODE approach, which is the acronym for topological substructural molecular descriptors/design [57] [58] [59] [60] [61] [62] . TOPS-MODE approach is based on the calculation of spectral moments of molecular bond matrices appropriately weighted to account for hydrophobic, electronic and steric molecular features. Spectral moments are the trace of the kth power of a matrix, i.e., the sum of all entries in the main diagonal of such matrices. The reader is referred to [57] [58] [59] to obtain full details of this method.
A bond matrix is a square symmetric matrix in which nondiagonal entries are ones or zeroes if the corresponding bonds have a common atom or not, respectively [67] . These matrices represent the molecular skeleton without taking into account hydrogen atoms. Bonds weights are placed as diagonal entries of such matrices and represent quantitative contributions to different physicochemical properties. Among bond weights currently in use in our approach we have standard bond distance (SD), standard bond dipole moments (DM), hydrophobicity (H) [68] , polar surface area (PS) [69] , polarizability (Pol) [70] , molar refractivity (MR) [70] , van der Waals radii (vdW) [71] , and Gasteiger-Marsilli charges (Ch) [72] .
The starting point for our approach is to calculate TOPS-MODE descriptors of the different types, e.g., H, PS, Pol, MR, vdW, and Ch, for the series of molecules under study. Then, we develop a quantitative model describing the property under study in terms of the spectral moments. In general this model can be of the following form:
where P is the property under study, The jth spectral moment of the bond matrix can be expressed as a sum of bond moments, which are simply the corresponding entries of the jth power of the bond matrix:
where j (i) is the bond moment of the ith bond in a molecule with m bonds. Then, model [2] can be written as:
where the right-hand side in (3) represents the contribution of bond i to the property P and is called the ''bond contribution'' and represented by P(i):
and the property P can be expressed as an additive function of bond contributions:
Bond contributions are numeric characterization of bonds which permit to identify some groups or regions of a molecular framework which can be responsible for a property/activity [73] . By carefully analyzing similar regions in different molecules we can obtain general rules about the contributions of molecular fragments to a particular property/activity. They are based on the substructural nature of TOPS-MODE. This procedure consists in transforming a QSPR or QSAR model into a bond additive scheme in which a property can be calculated as the sum of bond contributions for a molecule.
Orthogonalization of TOPS-MODE Descriptors
One of the inherent characteristic of the TOPS-MODE approach is that spectral moments are collinear among them. This means that there is redundancy in the information contained in any pair of collinear descriptors. Two descriptors are called collinear if they have a significant linear correlation between them as measured by the linear correlation coefficient. The main drawback of collinearity from the point of view of a QSAR model is that of the stability of the coefficients in the linear regression model. This introduces a difficulty in interpreting the models obtained with collinear variables because the sign and magnitude of the coefficients in the regression model can be affected by the removal or introduction of a new variable in the model. In the case of the TOPS-MODE approach this can be traduced into false interpretation of bond contributions because the magnitude and sign of them can be falsified by the effect produced by the existence of collinear variables in the model. Consequently, we have implemented the Randi 's method of orthogonalization [74] [75] [76] to eliminate the collinearities between the TOPS-MODE variables. In doing so, we have developed a new approach to extract the information contained in these variables after orthogonalization. The Randi 's method of orthogonalization has been described in details in several publications [74] [75] [76] [77] [78] . Thus, we will give only a general overview here. The first step in orthogonalizing the molecular descriptors is to select the appropriate order of orthogonalization, which in this case is the order in which the variables were selected in the forward stepwise search procedure of the linear discriminant analysis. The first variable 1 ( ) is taken as the first orthogonal descriptors 1 1 ( ) and the second one is orthogonalized respect to it by taking the residual of its correlation with ( ) . The process is repeated until all variables are completely orthogonalized and the orthogonal variables are then used to obtain the new model. Let consider the following QSAR/QSPR model:
, then the orthogonalization of the independent variables is carried out as follows:
The orthogonalized variables are then: X 1 , (X 2 ) and 2 (X 3 ) and the coefficients in steps (ii) -(iv) are obtained by linear regression analysis.
In order to extract the information contained in the orthogonalized descriptors, i.e., bond contributions, we implemented the following iterative procedure:
Calculate bond contributions to (X 1 ) :
Calculate bond contributions to
The final bond contributions are
This procedure represents the extraction of the information contained into a bond contribution of a variable which is duplicated by the other variables in the model.
CLASSIFICATION MODEL
A linear discriminant model was developed using our training data set (TSET) of 345 compounds. The model contains six TOPS-MODE descriptors accounting for hydrophobic, electronic and steric features of molecules. The model classifies correctly 86.7% of the total number of compounds in the TSET (88.4% for substrate and 84.3% of good classification for non-substrate compounds). The percentage of false actives in the training set was only 11.6% (23 inactive compounds were classified as actives from 345 cases), and 15.7% were false inactives (23 substrate compounds were classified as inactive).
The classification function to discriminate P-gp substrate from P-gp nonsubstrates, in the compounds belonging to the training set, is given below together with the statistical parameters of the LDA ( is the Wilks' statistics, D 2 is the squared Mahalanobis distance and F is the Fisher ratio): 
This model shows the best performance in predicting Pglycoprotein activity in both the TSET and PSET among all the models generated using TOPS-MODE descriptors and linear discriminant analysis. In Table 2 we give the classification of all compounds used in the training and test sets by using this model.
As can be seen in the above equation, six variables are present in the model and some of them are spectral moments of high order. Taking into consideration that these variables could be mathematically collinear and over-fitting results can be produced, the Randic's orthogonalization procedure [74] [75] [76] , in order to avoid the collinearity among different variables was carried out.
Then, we proceed to orthogonalize the variables in this model in order to eliminate any collinearity present among the variables included in the model. Following the Randic´s orthogonalization procedure previously described we generate the following orthogonal classification model: (8) where m μ k w ( ) . Where, the symbol means orthogonal, m is the degree of importance of the descriptor to explain the property determined by the order in which it is selected by forward stepwise analysis, μ k is the kth spectral moment and w is the bond weight used. In this analysis the least squares method selected all orthogonal analogs of collinear variables. It ensured us that, in spite of collinear variables, each one has an amount of information not encoded in the others and the relative importance of each variable can be determined [74] [75] [76] .
The variables in the model (Eq. 8) encoded specific structural information, being the most influential descriptors those weighted with standard bond distance, polarizability and the atomic charge. On the other hand, the inclusion of polarizability is a complement of the bond distance since both are influenced by the electronegativity of the atoms that form the bond. Another computational study of 22 diverse drugs revealed that molecular descriptors associated with strong hydrogen bonding strength and high polarizability promote increased P-gp ATPase activity [45] . In general, these three properties are taken several times into account in the scientific literature, emphasizing the bond distance and the atomic charges [12, 15, 22, 23, 25, 33, 41, 44, 45, 47, 49, 50, 52, 53] .
We remark here that the classification of compounds using the orthogonalized model is exactly the same that those using the nonorthogonalized one and that the main differences are in the interpretation of the results. As can be seen there are not changes in the sign of coefficients. However, the relative contribution of the variables in the orthogonalized model is significantly different compared to those in the non-orthogonalized one. For instance, the variables μ 4 SD and μ 5 Ch have practically similar contributions (in absolute terms) in the non-orthogonalized model. However, in the orthogonalized model the contribution of μ 5 Ch is five times larger than that of μ 4 SD . These differences in the relative importance of the variables in both models can influence the contributions of the different bonds to the P-glycoprotein activity of the compounds under study, which are the main purpose of our research. The most important criterion for the quality of the discriminant model is based on the statistics for the external prediction set. In the PSET the percentage of good classification is 81.8% (82.0% for substrate and 80.2% for non-substrate). For this prediction set the false active rate is 18.0% and 19.8% the false inactives one. It is desirable that the number of false active compounds be as low as possible because this number represents inactive compounds that will be sent to the biological assays with the consequent loss of time and resources. Finally, the predictive capacity of the computational model was assessed by three data sets. The first set of compounds was composed by those listed in Table 1 . These compounds are moderate according to [53] , but classified as substrates and nonsubstrates by other authors (see Table 1 ). In Table 3 , we present the results obtained by using Eq. (7) in predicting the activity of compounds in Table 1 .
The percentage of good classification is 80.0%, 71.4% for substrate (5/7) and 100% for non-substrate (3/3). Our classification of Mequitazine (substrate) and Imipramine (non-substrate) coincides with predictions made by Cabrera et. al. [25] , when using these compounds in an external validation set related to commercial drugs. The second set of compounds was composed by 35 commercial drugs with reported values of P-gp activity [25] (see Table 4 ).
The predictivity of the model for this external validation set was 85.71% and the specificity was 71.43% for a general accuracy of 74.29%. From these compounds three drugs were erroneously predicted with a classification probability higher than 0.9. These drugs, Naloxone, Naltrexone and Indomethacin, have been described in the literature as potent inhibitors of the drug transporter, P-gp [80] [81] [82] . The third set of compounds was composed by 40 commercial drugs with reported values of P-gp activity, all of them as substrates [83] (see Table 5 ). As provided in Table 5 IC 50 values have been obtained for several commercially available compounds. In the case of those compounds having IC 50 > 90 we have decided to evaluate only those for which their activity as substrate is confirmed by at least other data source as provided in the references given in Table 5 .
The percentage of good classification for this data set using our model is 83.3 %. We have to remark that from all compounds in this dataset we have excluded 18 due to the following reasons: one chemical (Propantheline) is electronically charged and current version of TOPS-MODE does not account for charged compounds; another compound is a Quinine isomer (Quinidine), not differentiated by current TOPS-MODE approach and the remaining 16 compounds have IC 50 > 90 and are not confirmed by other sources to be substrate. Their numbers are: 6, 8, 10, 13, 17-19, 21, 25-29, 31, 34 and 37. Among those compounds which are not correctly classified by our model chlorpromazine has been considered to display only moderate activity [15, 53] (see Table 4 ). On the other hand, itraconazole has been considered as moderate by some authors [15, 53] and as inactive by others [25] , which agree with our classification of this compound as uncertain (U). Finally, amitryptiline and rofecoxib are wrongly classified and they display IC 50 > 50.
DISCUSSION
Although several computational models have been carried out to classified the P-gp substrate only two studies had used reasonably large data sets (see Table 6 ). A quantitative comparison among previous studies is not possible basically due to the differences in the composition of the data sets used. Nevertheless, a qualitative comparison may provide some results of the use of our model with respect to those reported in other studies. In Table 6 we show the results obtaioned by some methods previously reported in the literature and the present approach.
From all the data sets previously analyzed, the training set of used for developing our model was the larger one, having a ratio of number of compounds per number of variables included in the model equal to 57.5. Also, if substrates (S), non-substrates (NS), and accuracy (A) values for the test set are considered, all other models, with the exception of the one reported by Penzotti et al. [49] , showed similar predictive quality, to each other. As can be seen in the Eq. 8, descriptors accounting for bond distance have positive contributions to the P-gp activity. We can think about N -Number of compounds in the training (T) and prediction (P) sets; V -number of variables in the model; R -compound-variables ratio; S -substrate; NS -non-substrate: Aaccuracy.
standard distance as in relation with the molecular size. Consequrntly, keeping the rest of parameters unaltered increasing molecular size tends to increase the chances for a compound to becaome a Pgp substrate. These results are in agreement with other reports [25, 46] . Another property which globally displays a positive contribution to P-gp activity is polarizability. In full agreement with results reported in other studies [45, 84, 85] . Finally, the effect of the atomic charge on the molecular bond is also related to the previous properties, showing that less electronegativity difference between the atoms that form a bond (C-N > C-O > C-F) is translated into larger contributions to the P-gp activity. This effect is explained by the negative coefficients in Eq. 8 of variables μ 5 Ch and μ 11 Ch . On the other hand, several relationships between simple molecular descriptors and P-gp activity class were studied. One striking relationship was observed between the first spectral moment weighted with the average bond distance ( 1 D ) and the P-gp classification (-1 for nonsubstrate and 1 for substrate) as shown in Fig. (2) . Among the 345 TSET molecules, Fig (2) illustrates a high area under the ROC curve equal to 0.85, which is notably different from the value from a random classifier (diagonal line) [86, 87] . A subsequent principal components analysis of 345 heterogeneous compounds demonstrated that 1 D codifies information different to other descriptors used in substrate/non-substrate P-gp studies. In a general sense, bond distance could be considered as a more general property, providing new information for distinguishing P-gp substrates from nonsubstrates.
Despite this reductionist analysis of variable of different types we have to remark that a holistic analysis os needed in order to get a better understanding of the process. In this sense TOPS-MODE approach not only permits the correct classification of heterogeneous data set according to the P-gp activity, but it also allows the determination of fragment contributions, which are important to interpret this relation in structural terms.
Generation of Structural Rules
In order to generate structural rules we start by calculating bond contributions for all bonds in every molecule studied. Using a similar approach Cabrera et. al. [25] have found two fragments with opposite contributions to the P-gp activity. Here we report by first time four new fragments with positive contribution to the P-gp. The contribution of these fragments, hereafter designated as F1, F2, F3 and F4, are 0.15, 0.09, 0.07 and 0.03 respectively. These fragments are the nucleus of the rules for the structurtal alerts later on defined. These fragments and their contributions are shown in Fig. (3) .
At this point we group molecules into chemical classes following a criterion of functional groups or similar molecular structural regions. For instance, we group together all compounds having Fluorine atom directly bonded to a benzene ring and we check that most of them have the same (qualitative) contribution for such similar regions, as displayed below: 
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When a pattern of substrate or P-gp is extended beyond a functional group to include a molecular region which is repeated in several compounds with the same fragment we select this region as the structural alert instead of the specific functional groups contained in such region, e.g.: Fig. (3) . List of new fragments having positive contributions to P-pg binding and their contributions determined by the model. 
1.857
As a matter of example we give in Table 7 the values of the bond contributions for Tetrahydroisoquinoline. Phenolic group has been shown to have negative contribution to P-pg binding [15] , which is also the case here. Note that after orthogonalizing the variables in the model the contributions of the bonds nearby -OH group also have negative contributions indicating the existence of a 'negative' region which extends beyond the functional group. More interestingly, if we sum together all bond contributions for the seven bonds of the phenolic group, the contribution before orthogonalization is positive, i.e., 0.299. However, as soon as the variables are orthogonalized this contribution is negative: -0.298, in agreement with previous findings [15] .
In order to extract functional rules as the previously exemplified we use fragments/molecular-regions which are represented in a large pool of compounds or which sounded chemico-biological information about its possible role in P-glycoprotein has been reported. When such structural rules are created we test them for robustness using our prediction sets of compounds. In Table 8 we give details for all the structural rules generated in this work, which include the prototype structure defining the structural alert, compounds in the dataset that display this fragment/region and some examples of them, identifying the bond contributions of the region responsible for the P-glycoprotein activity. We have to remark that the way for using such structural alerts or rules is in the 'classical' IF-THEN way of expert systems. That is, IF 'structural alert x' is present in a molecule, THEN 'this molecule is a P-pg substrate'.
Using the previously mentioned criteria we have selected 24 structural alert rules accounting for the following structural classes of compounds: Benzimidazolone and Benzoindolinone; Benzimidazole; Indole; Benzodioxole and Benzodioxine; Pyrimido pyrimidine; Pteridine, Tetrahydroisoquinoline; Quinoline; Isoquinoline; Phenothiazine; Thioxanthene and Xanthene; Dibenzepine saturated and unsaturated; Benzoic acid derivatives; Benceneacetonitrile; Ethylphenylacetate and analogs; Diphenylmethane and Diphenylalkyl derivatives; 1H-Indene; 1,3-Dioxolane with Imidazole or Triazole; Imidazole; Azepane; compounds with piperidinyl ring; compounds with piperazinyl ring; compounds with nitrogen in an heterocyclic ring and compounds with nitrogen and oxygen in an heterocyclic ring. Note that obviously one compound can have more than one structural alert.
As can be seen in all the structural alerts rules defined here the secundary and tertiary forms of N are presents (see example in [29, 36, 104, 154, 171, 188, 196, 263] Table 7) . It is well known [15, 23, 41, 50] that nitrogen atom (positively charged or not) has an important role in the binding of substrates to P-gp. According to Stouch [23] , the most striking result of the study by Klopman [15] was the importance of a dialkylsubstituted amine. Some progresses have been made in uncovering pharmacophores responsible for activity. Even for reversing agents, Klopman et al. [15] have confirmed the importance of specific structural features and have proposed a nascent pharmacophore about the studied secondary amine. It should be noted that 260 of the 609 had a secondary amine. A biophore referred to by Klopman [15] (in his Table 2 ) in the generic form of C-C-X-C-C, where X = N, NH, or O (preferably a tertiary nitrogen), linked to two unsubstituted alkyl groups, is consistent with our results. In fact, this fragment is present in all alerts proposed here in two alternative geometric shapes cis and trans. This orientation is selected in agreement with the presentation about P-gp as a H-bond donor/acceptor and the neutral drug forms used [88] . In particular, stereoisomers of Thioxanthenes (rule number 11) can have two different shapes depending on the direction of the aliphatic chain toward the second position substituent in the ring system: in the same direction as (cis forms) or opposite to (trans form) the substituent [89] .
The other biophores that appear in the above-mentioned Most models developed up to now identify the minimal requirements of involving one or two hydrophobic centers including one or two aromatic rings, one to three H-bond acceptors (>N-, -OH, =O), and/or one H-bond donor (>N-, -OH, =NH, -NH-) [41] . The most active ligands should have more pharmacophore contact points simultaneously occupied [41] . Examples of P-glycoprotein substrates with pharmacophore contact points identified according to Raub [41] coincide with our structural alerts. Phenotiazines are one of the most abundant compounds in our datasets, having a total of 26 chemicals (18 in training serie and 8 in prediction one). They are characterized by our structural rule # 10. An outstanding aspect for this family selection is related to the fact that the model used here classifies and predict 100 % of these 26 structures. Two of them, Promethazine (compound 136) and Prochlorperazine (compound 150) are classified with 83.98 and 80.48 %, respectively. These compounds have RF values of 7.5 and 6.7, respectively and log (MDR) values of 0.279 and 0.415, respectively [89] .
CONCLUSION
The prediction of the P-gp activity has been a goal of pharmaceutical research. For this reason, several in silico methods have been applied in order to predict this property in the early stage of drug development and some of them have become important tools to select new drug candidates. In this study, the TOPS-MODE approach has been a successful methodology for classifying P-gp substrate/non-substrate compounds. We have shown the relevance of bond distance, polarizability and the atomic charge as bond weights in the bond matrix for describing P-gp binding. The most relevant aspect of the current approach is that it has permitted the identification and quantification of fragment contributions that are responsible of the P-gp activity for any molecular structure. These fragment contributions have been expressed here as structural alerts/rules, which are easily implementable in expert systems and computer-aided tools. We hope that this work contributes to the efforts of finding predictive and interpretable models for pharmaceutical properties of molecules.
